Abbott Laboratories (NYSE:ABT) is one of the defensive stocks that billionaires are buying amid US trade tariff uncertainty.

UBS has released its latest list of top stock picks following the July update, maintaining a neutral stance on U.S. equities ...

Amid trade tariff uncertainties, billionaires are snagging shares of Abbott Laboratories (ABT), a move underscored by UBS's recent reaffirmation of a 'Buy' rating with a $148 price target. Despite a ...